P1705: PATIENT-REPORTED OUTCOMES IN MYELOPROLIFERATIVE NEOPLASMS IN CLINICAL TRIALS: A SYSTEMATIC REVIEW

• E. N. Oliva,
• S. Salek,
• E. Laane,
• M. Andreas,
• M. Csenar,
• N. Skoetz,
• T. Ionova

Affiliations

E. N. Oliva

1 Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy

S. Salek

2 School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom

E. Laane

3 Department of Hematology and Oncology, University of Tartu, Tartu, Estonia

M. Andreas

4 Department I of Internal Medicine, Evidence-based Oncology, University Hospital of Cologne, Cologne, Germany

M. Csenar

4 Department I of Internal Medicine, Evidence-based Oncology, University Hospital of Cologne, Cologne, Germany

N. Skoetz

4 Department I of Internal Medicine, Evidence-based Oncology, University Hospital of Cologne, Cologne, Germany

T. Ionova

5 St. Petersburg State University Hospital, Saint-Petersburg, Russia